Back to MW MARSHALL WACE, LLP

SCPHSCPH
11 quarters

Position history for MWMARSHALL WACE, LLP's holdings in SCPHARMACEUTICALS INC

As of its Q3 2025 13F, Marshall Wace held 26,880 shares of SCPH (Scpharmaceuticals), worth $152,410.

Final Value

$0

Final Shares

0

Total Value Change

-$808,073

Total Shares Change

-112,702

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q3
New
26,880
-
$152,4100.0%—
31
2025-Q2
Exited
0
-100.0%
$00.0%—
0
2025-Q1
New
73,210
-
$192,5430.0%—
31
2024-Q4
Exited
0
-100.0%
$00.0%—
0
2024-Q3
New
23,646
-
$107,8250.0%—
30
2024-Q1
Exited
0
-100.0%
$00.0%—
0
2023-Q4
New
34,369
-
$215,4930.0%—
32
2023-Q2
Exited
0
-100.0%
$00.0%—
0
2023-Q1
Decreased
52,380
-53.5%
$475,0870.0%—
0
2022-Q4
New
112,702
-
$808,0730.0%—
34

Other major holders of SCPH: RTW INVESTMENTS, LP, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used